FDA's Oncology Center Of Excellence On Equal Terms With CDER In New Org Chart

While OCE has a lofty status, it has yet to gain a large cadre of staff.

FDA entrance sign 2016

FDA's Oncology Center of Excellence, its new face for oncology drug development, is now officially on the agency organization chart.

OCE is on par with Center for Drug Evaluation and Research (CDER), as well as the biologics and device centers, under a new organizational structure. FDA announced the change in a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA

More from Agency Leadership